Legal Advantage Investments, Inc. Astrazeneca PLC Transaction History
Legal Advantage Investments, Inc.
- $179 Million
- Q4 2024
A detailed history of Legal Advantage Investments, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Legal Advantage Investments, Inc. holds 3,950 shares of AZN stock, worth $266,980. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,950
Previous 4,150
4.82%
Holding current value
$266,980
Previous $323,000
20.12%
% of portfolio
0.14%
Previous 0.19%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,380Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.08 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.77 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.54 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.62 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $209B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...